| pubmed-article:11483215 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11483215 | lifeskim:mentions | umls-concept:C0949945 | lld:lifeskim |
| pubmed-article:11483215 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:11483215 | lifeskim:mentions | umls-concept:C0679932 | lld:lifeskim |
| pubmed-article:11483215 | lifeskim:mentions | umls-concept:C0014441 | lld:lifeskim |
| pubmed-article:11483215 | pubmed:issue | 1-2 | lld:pubmed |
| pubmed-article:11483215 | pubmed:dateCreated | 2001-8-2 | lld:pubmed |
| pubmed-article:11483215 | pubmed:abstractText | A solid-phase competition ELISA has been developed to measure antibodies to foot-and-mouth disease (FMD) virus and has been validated using an extensive range of sera from cattle. The assay uses polyclonal antisera and inactivated purified 146S antigens of FMD virus and was compared with the liquid-phase blocking ELISA and the virus neutralisation test on a range of serum sets. When examining test sera at a 1:5 dilution with a cut-off point of 30% inhibition of reaction, the solid-phase competition ELISA was as sensitive as the liquid-phase blocking ELISA for sera from infected or vaccinated animals. The limit of detection of the solid-phase ELISA was similar to that of the liquid-phase assay and both tests had lower limit of detection (i.e. were able to detect lower amounts of antibody) than the virus neutralisation test. The specificity of the solid-phase ELISA was considerably higher than that of the liquid-phase blocking ELISA and almost equivalent to that of the virus neutralisation test. The assay thus retains the sensitivity of the liquid-phase blocking ELISA whilst being easier to use, more robust and specific, and therefore offers an improvement for FMD virus antibody detection. | lld:pubmed |
| pubmed-article:11483215 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11483215 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11483215 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11483215 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11483215 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11483215 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11483215 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11483215 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:11483215 | pubmed:issn | 0166-0934 | lld:pubmed |
| pubmed-article:11483215 | pubmed:author | pubmed-author:DavidsonFF | lld:pubmed |
| pubmed-article:11483215 | pubmed:author | pubmed-author:FerrisN PNP | lld:pubmed |
| pubmed-article:11483215 | pubmed:author | pubmed-author:MackayD KDK | lld:pubmed |
| pubmed-article:11483215 | pubmed:author | pubmed-author:BulutA NAN | lld:pubmed |
| pubmed-article:11483215 | pubmed:author | pubmed-author:RendleTT | lld:pubmed |
| pubmed-article:11483215 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11483215 | pubmed:volume | 97 | lld:pubmed |
| pubmed-article:11483215 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11483215 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11483215 | pubmed:pagination | 33-48 | lld:pubmed |
| pubmed-article:11483215 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11483215 | pubmed:meshHeading | pubmed-meshheading:11483215... | lld:pubmed |
| pubmed-article:11483215 | pubmed:meshHeading | pubmed-meshheading:11483215... | lld:pubmed |
| pubmed-article:11483215 | pubmed:meshHeading | pubmed-meshheading:11483215... | lld:pubmed |
| pubmed-article:11483215 | pubmed:meshHeading | pubmed-meshheading:11483215... | lld:pubmed |
| pubmed-article:11483215 | pubmed:meshHeading | pubmed-meshheading:11483215... | lld:pubmed |
| pubmed-article:11483215 | pubmed:meshHeading | pubmed-meshheading:11483215... | lld:pubmed |
| pubmed-article:11483215 | pubmed:meshHeading | pubmed-meshheading:11483215... | lld:pubmed |
| pubmed-article:11483215 | pubmed:meshHeading | pubmed-meshheading:11483215... | lld:pubmed |
| pubmed-article:11483215 | pubmed:meshHeading | pubmed-meshheading:11483215... | lld:pubmed |
| pubmed-article:11483215 | pubmed:meshHeading | pubmed-meshheading:11483215... | lld:pubmed |
| pubmed-article:11483215 | pubmed:meshHeading | pubmed-meshheading:11483215... | lld:pubmed |
| pubmed-article:11483215 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11483215 | pubmed:articleTitle | A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus. | lld:pubmed |
| pubmed-article:11483215 | pubmed:affiliation | Institute for Animal Health, Pirbright Laboratory, Ash Road, Pirbright, Woking, GU24 0NF, Surrey, UK. | lld:pubmed |
| pubmed-article:11483215 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11483215 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11483215 | lld:pubmed |
